Médecine

Paramédical

Autres domaines


S'abonner

When science goes viral: The research response during three months of the COVID-19 outbreak - 28/08/20

Doi : 10.1016/j.biopha.2020.110451 
Joanna Nowakowska a, 1, Joanna Sobocińska a, 1, Mateusz Lewicki b, Żaneta Lemańska a, Piotr Rzymski c, d,
a Poznan University of Medical Sciences, Fredry 10, 61-701, Poznań, Poland 
b Pomeranian Medical University in Szczecin, Rybacka 1, 70-204, Szczecin, Poland 
c Department of Environmental Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806, Poznań, Poland 
d Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Poznań, Poland 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Highlights

A bibliometric study on the first 3 months of research on COVID-19 was performed.
A total of 2062 articles in 578 journals and 1425 preprints were identified.
The scientific contributions from 73 countries were seen.
The highest number of original research emerged from China.
The scientific response to COVID-19 is unprecedented.

Le texte complet de cet article est disponible en PDF.

Abstract

Here we present the results of a bibliometric survey of peer-reviewed and pre-print papers published in the English language on issues related to COVID-19 within the first three months since a cluster of a severe acute respiratory disease of unknown etiology was officially confirmed by the Chinese Center for Disease Control and Prevention on 31 December 2019. A systematic search using PubMed/Medline and Scopus databases and preprint servers was performed. The articles were classified according to their type, subject and country of origin. Up to 31 March 2020, a total of 2062 papers published in 578 peer-reviewed journals and 1425 preprints posted mostly on medRxiv (55.4 %), were identified. The mean number of published journal papers and preprints per day in the considered period was 27 and 12, respectively, and reached a maximum of 51 and 46 per day in March, respectively. The identified articles, journal papers and preprints, mostly covered the epidemiology of COVID-19 (35.7 %), clinical aspects of infection (21.0 %), preventative measures (12.8 %), treatment options (12.5 %), diagnostics (12.2 %), mathematical modeling of disease transmission and mitigation (9.6 %), and molecular biology and pathogenesis of SARS-CoV-2 (8.7 %). The majority of the journal papers were commentaries (38.5 %), reviews (33.6 %) and original research (21.3 %), while preprints predominantly presented original results (89.8 %). Chinese scientists contributed the highest share of original research and were responsible for 32.9 % journal papers and 43.9 % preprints published in the considered period. A high number of contributions was also seen from the United States, the United Kingdom, and Italy. The benefits and potential risks of such a massive publication output are discussed. The scientific response seen during the first 3 months of the COVID-19 outbreak is a demonstration of the capabilities of modern science to react rapidly to emerging global health threats by providing and discussing the essential information for understanding the etiological factor, its spread, preventative measures, and mitigation strategies.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, SARS-CoV-2, Emerging infectious disease, Bibliometric analysis, Academia


Plan


© 2020  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129

Article 110451- septembre 2020 Retour au numéro
Article précédent Article précédent
  • The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis
  • Jie Lin, Han-fei Huang, Shi-kun Yang, Jian Duan, Si-ming Qu, Bo Yuan, Zhong Zeng
| Article suivant Article suivant
  • Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain
  • Amal Thomas, Bright N. Okine, David P. Finn, Willias Masocha

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.